PDCD1 and hematologic disorder: In this search for new and more efficient therapies [10], heat shock proteins (HSPs) and, more recently, the programmed cell death 1 (PD-1)/programmed death ligand 1 (PD-L1) axis have been found to be of great interest in hematologic malignancies.